Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible

Despite the availability of antifibrotic therapies, many patients with idiopathic pulmonary fibrosis (IPF) will progress to advanced disease and require lung transplantation. International guidelines for transplant referral and listing of patients with interstitial lung disease are not specific to t...

Full description

Saved in:

Bibliographic Details
Published in:	Medicina (Kaunas, Lithuania) Lithuania), 2019-10, Vol.55 (10), p.702
Main Authors:	Balestro, Elisabetta, Cocconcelli, Elisabetta, Tinè, Mariaenrica, Biondini, Davide, Faccioli, Eleonora, Saetta, Marina, Rea, Federico
Format:	Article
Language:	eng
Subjects:	acute exacerbation comorbidities Comorbidity Humans idiopathic pulmonary fibrosis Idiopathic Pulmonary Fibrosis - therapy lung transplantation Lung Transplantation - methods Lung Transplantation - standards Referral and Consultation - standards Referral and Consultation - trends Review Survival Analysis Time Factors
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Despite the availability of antifibrotic therapies, many patients with idiopathic pulmonary fibrosis (IPF) will progress to advanced disease and require lung transplantation. International guidelines for transplant referral and listing of patients with interstitial lung disease are not specific to those with IPF and were published before the widespread use of antifibrotic therapy. In this review, we discussed difficulties in decision-making when dealing with patients with IPF due to the wide variability in clinical course and life expectancy, as well as the acute deterioration associated with exacerbations. Indeed, the ideal timing for referral and listing for lung transplant remains challenging, and the acute deterioration might be influenced after transplant outcomes. Of note, patients with IPF are frequently affected by multimorbidity, thus a screening program for occurring conditions, such as coronary artery disease and pulmonary hypertension, before lung transplant listing is crucial to candidate selection, risk stratification, and optimal outcomes. Among several comorbidities, it is of extreme importance to highlight that the prevalence of lung cancer is increased amongst patients affected by IPF; therefore, candidates' surveillance is critical to avoid organ allocation to unsuitable patients. For all these reasons, early referral and close longitudinal follow-up for potential lung transplant candidates are widely encouraged.
ISSN:	1648-9144 1010-660X 1648-9144